Novartis Japan Unit Failed To Notify Ministry Of 2,579 Serious Side Effects
This article was originally published in PharmAsia News
Executive Summary
Novartis Pharma K.K. disclosed that it failed to report as required 2,579 serious side effects cases for several of its drugs in Japan, 1,313 of them related to its Glivec (imatinib) for leukemia.